期刊
FUTURE ONCOLOGY
卷 10, 期 13, 页码 2015-2021出版社
FUTURE MEDICINE LTD
DOI: 10.2217/FON.14.154
关键词
anaplastic thyroid cancer; fosbretabulin; tubulin-binding agent
类别
Fosbretabulin tromethamine is a vascular disrupting agent, which is a type of drug that is designed to damage the vasculature (blood vessels) of cancer tumors, causing central necrosis. This drug showed activity against anaplastic thyroid cancer that was demonstrated in orthotopic xenograft models as well as in Phase I/II trials with or without carboplatin and paclitaxel combination therapy. In all of these studies, fosbretabulin was well tolerated.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据